Compare SGP & MAKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGP | MAKO |
|---|---|---|
| Founded | 2019 | 2004 |
| Country | United States | Canada |
| Employees | N/A | 30 |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 799.4M | 861.6M |
| IPO Year | 2026 | N/A |
| Metric | SGP | MAKO |
|---|---|---|
| Price | $24.92 | $9.35 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $44.00 | N/A |
| AVG Volume (30 Days) | 108.2K | ★ 142.1K |
| Earning Date | 11-10-2026 | 11-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $74.32 |
| Revenue Next Year | N/A | $0.38 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.06 | $6.58 |
| 52 Week High | $30.56 | $11.10 |
| Indicator | SGP | MAKO |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 45.85 |
| Support Level | $24.85 | $6.74 |
| Resistance Level | $26.29 | $10.64 |
| Average True Range (ATR) | 1.43 | 0.31 |
| MACD | -0.37 | -0.10 |
| Stochastic Oscillator | 29.19 | 40.92 |
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
Mako Mining Corp is a gold mining, development, and exploration firm. The companies primary asset is the San Albino mine, an open-pit mine located in Nicaragua. In addition to its mining operation, the company continues to explore its other concessions in Nicaragua and Guyana.